Objective To investigate the therapeutic effects of Saussurea involucrate injection in severe acute pancreatitis (SAP) in rats.Methods A total of 80 healthy Sprague-Dawley rats were divided into eight groups:SAP group (three hours、48 hours),Saussurea involucrate treated group (three hours、48 hours),ulinastatin control group (three hours、48 hours) and sham operation group (three hours、48 hours),10 rats in each group.After modeling,the rats of SAP group were regularly feeded and the rats of other three group were treated with Saussurea involucrate injection (1.04 mL/kg) intraperitoneal injection,ulinastatin 10 000 U/L tail vein injection,and saline femoral vein injection,respectively and injected every 12 hours.At three hours and 48 hours after treated,blood and pancreatic tissue samples were obtained.The mortality rate,serum amylase level and pathological changes of the pancreas of each group were observed.Serum tumor necrosis factor alpha (TNF-α),interleukin (IL)-6 and IL-10 levels were detected by enzyme linked immunosorbent assay (ELISA).The content of malondialdehyde (MDA) in pancreatic tissues was determined by chemical colorimetry.The level of TNF-α mRNA,IL 6 mRNA and IL-10 mRNA in pancreatic tissues were measured with reverse trascription-polymerase chain reaction (RT-PCR).The activity of nuclear factor kappa B p65 (NF-κB p65) in the pancreatic tissue was tested by immunohistochemistry.Single factor analysis of variance was used to compare multiple groups,and the least significant difference (LSD) method was used in the multiple comparisons between groups.Fisher's exact probability method was performed for rates comparison.Results At 48 hours,there was no statistically significant difference in mortality rate among Saussurea involucrate treated group,SAP group and ulinastatin groups (all P＞0.05).At 48 hours,the histopathology score (8.13 ± 0.64),levels of serum amylase ((2 597.0±214.0) U/L),TNF-α ((254.4±11.6) ng/L),IL-6 ((441.4±14.6) ng/L),levels of pancreatic tissues MDA ((311.0±10.6) mmol/L),TNF-α mRNA(2.04±0.08),IL-6 mRNA (1.77±0.04)and activity of NF-κB p65 ((25.90±2.90)％) of Saussurea involucrate treated group were all lower than those of SAP group (11.40±0.89,(4 780.0±101.0) U/L,(396.0±7.4) ng/L,(664.4± 7.6) ng/L,(418.0± 10.6) mmol/L,2.94±0.03,2.63±0.08 and (51.60±5.27) ％;however level of serum IL-10 ((133.5±6.9) ng/L vs (95.1±5.2) ng/L) and IL-10 mRNA of the pancreatic tissue (1.38±0.06 vs 0.85±0.03) significantly increased (F=253.07、441.63、489.40、2 465.00、196.65、477.89、562.79、131.70、560.18、570.04,all P＜0.01).There was no significant differences in all above parameters between Saussurea involucrate treated group and ulinastatin groups (7.56±0.88,(2 607.0±239.0) U/L,(252.2 ±9.2) ng/L,(443.4±9.6) ng/L,(308.4±9.2) mmol/L,2.10±0.12,1.74±0.04,(26.00±3.67)％,(134.5±7.8) ng/L and 1.42±0.06) at 48 hours (all P＞0.05).Conclusion Saussurea involucrate injection can eliminate oxygen free radicals and prevent to xidation,inhibit NF-κB activation,regulate synthesis and release of cytokines,and alleviate pancreatic injury in SAP rats,but it can not decrease mortality.

Objective To investigate the clinical value of gallbladder function in predicting postoperative complications after endoscopic treatment of calculus of common bile duct.Methods 118 patients with complete gallbladder who underwent endoscopic clearance for calculus of common bile duct were selected from January 2018 to December 2022.After the liver function recovered to normal,the patients underwent lipid meal ultrasound examination to evaluate fasting volume,residual volume,and gallbladder ejection fraction(GBEF).The relationship between clinical features,gallbladder function and recurrent biliary complications was analyzed in patients with calculus of common bile duct.Results Among the 118 patients with calculus of common bile duct,86 had concomitant cholecystolithiasis,while 32 did not.During the follow-up period,23 patients developed biliary complications.Among the 86 patients with concomitant cholecystolithiasis,15 had spontaneous clearance of cholecystolithiasis,14 underwent cholecystectomy due to acute cholecystitis or recurrent abdominal pain,and 6 died of non-biliary causes.The GBEF of the patients with cholecystolithiasis was significantly lower.Cholecystolithiasis,alcohol consumption,and more than one endoscopic treatment were the risk factors for recurrent biliary complications after endoscopic treatment of calculus of common bile duct.Conclusion Patients with calculus of common bile duct combined with cholecystolithiasis have poor GBEF.Cholecystolithiasis,alcohol consumption,and more than one endoscopic treatment are the risk factors for recurrent biliary complications after endoscopic treatment of calculus of common bile duct.Since cholecystolithiasis may spontaneously resolve,conservative monitoring of the gallbladder after endoscopic treatment for calculus of common bile duct is appropriate,but regular follow-up is necessary for high-risk patients.